 | • レポートコード：MRC2-11QY10854 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は強直性脊椎炎治療のグローバル市場について調査・分析したレポートです。種類別（疾患修飾性抗リウマチ薬（DMARD）、非ステロイド性抗炎症薬（NSAID）、生物学的製剤）市場規模、用途別（若年、成人）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別強直性脊椎炎治療の競争状況、市場シェア ・世界の強直性脊椎炎治療市場：種類別市場規模 2015年-2020年（疾患修飾性抗リウマチ薬（DMARD）、非ステロイド性抗炎症薬（NSAID）、生物学的製剤） ・世界の強直性脊椎炎治療市場：種類別市場規模予測 2021年-2026年（疾患修飾性抗リウマチ薬（DMARD）、非ステロイド性抗炎症薬（NSAID）、生物学的製剤） ・世界の強直性脊椎炎治療市場：用途別市場規模 2015年-2020年（若年、成人） ・世界の強直性脊椎炎治療市場：用途別市場規模予測 2021年-2026年（若年、成人） ・北米の強直性脊椎炎治療市場分析：米国、カナダ ・ヨーロッパの強直性脊椎炎治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの強直性脊椎炎治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の強直性脊椎炎治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの強直性脊椎炎治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbvie、Amgen、Janssen Biotech、Merck、UCB、Boehringer Ingelheim、Johnson & Johnson ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and pain in the ligaments and tendons. These symptomatic changes may be mild or severe, and may lead to a stooped-over posture. The prevalence of ankylosing spondylitis is seen in about 0.1% to 0.5% of the adult population worldwide. It can occur at any age irrespective of gender; however, higher prevalence has been observed among males between the ages of 15–30 years.
The ankylosing spondylitis treatment market is growing at a significant rate due to the increasing prevalence of ankylosing spondylitis and rising awareness about diagnostics and treatments for the disease. In addition, government initiatives and improving healthcare infrastructure are driving the market for ankylosing spondylitis treatment. However, factors such as the high cost of treatment and lack of skilled surgeons and physiotherapists restrain the market from growing.
Market Analysis and Insights: Global Ankylosing Spondylitis Treatment Market
The global Ankylosing Spondylitis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Ankylosing Spondylitis Treatment Scope and Market Size
Ankylosing Spondylitis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ankylosing Spondylitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbvie
Amgen
Janssen Biotech
Merck
UCB
Boehringer Ingelheim
Johnson & Johnson
…
Market segment by Type, the product can be split into
Disease-Modifying Anitrheumatic Drugs (DMARDs)
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Biologics
Market segment by Application, split into
Juveniles
Adults
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ankylosing Spondylitis Treatment Revenue
1.4 Market by Type
1.4.1 Global Ankylosing Spondylitis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Disease-Modifying Anitrheumatic Drugs (DMARDs)
1.4.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
1.4.4 Biologics
1.5 Market by Application
1.5.1 Global Ankylosing Spondylitis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Juveniles
1.5.3 Adults
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Ankylosing Spondylitis Treatment Market Perspective (2015-2026)
2.2 Global Ankylosing Spondylitis Treatment Growth Trends by Regions
2.2.1 Ankylosing Spondylitis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Ankylosing Spondylitis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Ankylosing Spondylitis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Ankylosing Spondylitis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Ankylosing Spondylitis Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Ankylosing Spondylitis Treatment Players by Market Size
3.1.1 Global Top Ankylosing Spondylitis Treatment Players by Revenue (2015-2020)
3.1.2 Global Ankylosing Spondylitis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Ankylosing Spondylitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Ankylosing Spondylitis Treatment Market Concentration Ratio
3.2.1 Global Ankylosing Spondylitis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Ankylosing Spondylitis Treatment Revenue in 2019
3.3 Ankylosing Spondylitis Treatment Key Players Head office and Area Served
3.4 Key Players Ankylosing Spondylitis Treatment Product Solution and Service
3.5 Date of Enter into Ankylosing Spondylitis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Ankylosing Spondylitis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Ankylosing Spondylitis Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Ankylosing Spondylitis Treatment Market Size by Application (2015-2020)
5.2 Global Ankylosing Spondylitis Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Ankylosing Spondylitis Treatment Market Size (2015-2020)
6.2 Ankylosing Spondylitis Treatment Key Players in North America (2019-2020)
6.3 North America Ankylosing Spondylitis Treatment Market Size by Type (2015-2020)
6.4 North America Ankylosing Spondylitis Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Ankylosing Spondylitis Treatment Market Size (2015-2020)
7.2 Ankylosing Spondylitis Treatment Key Players in Europe (2019-2020)
7.3 Europe Ankylosing Spondylitis Treatment Market Size by Type (2015-2020)
7.4 Europe Ankylosing Spondylitis Treatment Market Size by Application (2015-2020)
8 China
8.1 China Ankylosing Spondylitis Treatment Market Size (2015-2020)
8.2 Ankylosing Spondylitis Treatment Key Players in China (2019-2020)
8.3 China Ankylosing Spondylitis Treatment Market Size by Type (2015-2020)
8.4 China Ankylosing Spondylitis Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Ankylosing Spondylitis Treatment Market Size (2015-2020)
9.2 Ankylosing Spondylitis Treatment Key Players in Japan (2019-2020)
9.3 Japan Ankylosing Spondylitis Treatment Market Size by Type (2015-2020)
9.4 Japan Ankylosing Spondylitis Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Ankylosing Spondylitis Treatment Market Size (2015-2020)
10.2 Ankylosing Spondylitis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Ankylosing Spondylitis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Ankylosing Spondylitis Treatment Market Size by Application (2015-2020)
11 India
11.1 India Ankylosing Spondylitis Treatment Market Size (2015-2020)
11.2 Ankylosing Spondylitis Treatment Key Players in India (2019-2020)
11.3 India Ankylosing Spondylitis Treatment Market Size by Type (2015-2020)
11.4 India Ankylosing Spondylitis Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Ankylosing Spondylitis Treatment Market Size (2015-2020)
12.2 Ankylosing Spondylitis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Ankylosing Spondylitis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Ankylosing Spondylitis Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbvie
13.1.1 Abbvie Company Details
13.1.2 Abbvie Business Overview
13.1.3 Abbvie Ankylosing Spondylitis Treatment Introduction
13.1.4 Abbvie Revenue in Ankylosing Spondylitis Treatment Business (2015-2020))
13.1.5 Abbvie Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview
13.2.3 Amgen Ankylosing Spondylitis Treatment Introduction
13.2.4 Amgen Revenue in Ankylosing Spondylitis Treatment Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 Janssen Biotech
13.3.1 Janssen Biotech Company Details
13.3.2 Janssen Biotech Business Overview
13.3.3 Janssen Biotech Ankylosing Spondylitis Treatment Introduction
13.3.4 Janssen Biotech Revenue in Ankylosing Spondylitis Treatment Business (2015-2020)
13.3.5 Janssen Biotech Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Ankylosing Spondylitis Treatment Introduction
13.4.4 Merck Revenue in Ankylosing Spondylitis Treatment Business (2015-2020)
13.4.5 Merck Recent Development
13.5 UCB
13.5.1 UCB Company Details
13.5.2 UCB Business Overview
13.5.3 UCB Ankylosing Spondylitis Treatment Introduction
13.5.4 UCB Revenue in Ankylosing Spondylitis Treatment Business (2015-2020)
13.5.5 UCB Recent Development
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Details
13.6.2 Boehringer Ingelheim Business Overview
13.6.3 Boehringer Ingelheim Ankylosing Spondylitis Treatment Introduction
13.6.4 Boehringer Ingelheim Revenue in Ankylosing Spondylitis Treatment Business (2015-2020)
13.6.5 Boehringer Ingelheim Recent Development
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Details
13.7.2 Johnson & Johnson Business Overview
13.7.3 Johnson & Johnson Ankylosing Spondylitis Treatment Introduction
13.7.4 Johnson & Johnson Revenue in Ankylosing Spondylitis Treatment Business (2015-2020)
13.7.5 Johnson & Johnson Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Ankylosing Spondylitis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Ankylosing Spondylitis Treatment Revenue
Table 3. Ranking of Global Top Ankylosing Spondylitis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Ankylosing Spondylitis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Disease-Modifying Anitrheumatic Drugs (DMARDs)
Table 6. Key Players of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Table 7. Key Players of Biologics
Table 8. Global Ankylosing Spondylitis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Ankylosing Spondylitis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Ankylosing Spondylitis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Ankylosing Spondylitis Treatment Market Share by Regions (2015-2020)
Table 12. Global Ankylosing Spondylitis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Ankylosing Spondylitis Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Ankylosing Spondylitis Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Ankylosing Spondylitis Treatment Players
Table 19. Global Ankylosing Spondylitis Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Ankylosing Spondylitis Treatment Market Share by Players (2015-2020)
Table 21. Global Top Ankylosing Spondylitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ankylosing Spondylitis Treatment as of 2019)
Table 22. Global Ankylosing Spondylitis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Ankylosing Spondylitis Treatment Product Solution and Service
Table 25. Date of Enter into Ankylosing Spondylitis Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Ankylosing Spondylitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Ankylosing Spondylitis Treatment Market Size Share by Type (2015-2020)
Table 29. Global Ankylosing Spondylitis Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Ankylosing Spondylitis Treatment Market Size Share by Application (2015-2020)
Table 31. Global Ankylosing Spondylitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Ankylosing Spondylitis Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Ankylosing Spondylitis Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Ankylosing Spondylitis Treatment Market Share (2019-2020)
Table 35. North America Ankylosing Spondylitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Ankylosing Spondylitis Treatment Market Share by Type (2015-2020)
Table 37. North America Ankylosing Spondylitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Ankylosing Spondylitis Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Ankylosing Spondylitis Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Ankylosing Spondylitis Treatment Market Share (2019-2020)
Table 41. Europe Ankylosing Spondylitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Ankylosing Spondylitis Treatment Market Share by Type (2015-2020)
Table 43. Europe Ankylosing Spondylitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Ankylosing Spondylitis Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Ankylosing Spondylitis Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Ankylosing Spondylitis Treatment Market Share (2019-2020)
Table 47. China Ankylosing Spondylitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Ankylosing Spondylitis Treatment Market Share by Type (2015-2020)
Table 49. China Ankylosing Spondylitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Ankylosing Spondylitis Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Ankylosing Spondylitis Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Ankylosing Spondylitis Treatment Market Share (2019-2020)
Table 53. Japan Ankylosing Spondylitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Ankylosing Spondylitis Treatment Market Share by Type (2015-2020)
Table 55. Japan Ankylosing Spondylitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Ankylosing Spondylitis Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Ankylosing Spondylitis Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Ankylosing Spondylitis Treatment Market Share (2019-2020)
Table 59. Southeast Asia Ankylosing Spondylitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Ankylosing Spondylitis Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Ankylosing Spondylitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Ankylosing Spondylitis Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Ankylosing Spondylitis Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Ankylosing Spondylitis Treatment Market Share (2019-2020)
Table 65. India Ankylosing Spondylitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Ankylosing Spondylitis Treatment Market Share by Type (2015-2020)
Table 67. India Ankylosing Spondylitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Ankylosing Spondylitis Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Ankylosing Spondylitis Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Ankylosing Spondylitis Treatment Market Share (2019-2020)
Table 71. Central & South America Ankylosing Spondylitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Ankylosing Spondylitis Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Ankylosing Spondylitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Ankylosing Spondylitis Treatment Market Share by Application (2015-2020)
Table 75. Abbvie Company Details
Table 76. Abbvie Business Overview
Table 77. Abbvie Product
Table 78. Abbvie Revenue in Ankylosing Spondylitis Treatment Business (2015-2020) (Million US$)
Table 79. Abbvie Recent Development
Table 80. Amgen Company Details
Table 81. Amgen Business Overview
Table 82. Amgen Product
Table 83. Amgen Revenue in Ankylosing Spondylitis Treatment Business (2015-2020) (Million US$)
Table 84. Amgen Recent Development
Table 85. Janssen Biotech Company Details
Table 86. Janssen Biotech Business Overview
Table 87. Janssen Biotech Product
Table 88. Janssen Biotech Revenue in Ankylosing Spondylitis Treatment Business (2015-2020) (Million US$)
Table 89. Janssen Biotech Recent Development
Table 90. Merck Company Details
Table 91. Merck Business Overview
Table 92. Merck Product
Table 93. Merck Revenue in Ankylosing Spondylitis Treatment Business (2015-2020) (Million US$)
Table 94. Merck Recent Development
Table 95. UCB Company Details
Table 96. UCB Business Overview
Table 97. UCB Product
Table 98. UCB Revenue in Ankylosing Spondylitis Treatment Business (2015-2020) (Million US$)
Table 99. UCB Recent Development
Table 100. Boehringer Ingelheim Company Details
Table 101. Boehringer Ingelheim Business Overview
Table 102. Boehringer Ingelheim Product
Table 103. Boehringer Ingelheim Revenue in Ankylosing Spondylitis Treatment Business (2015-2020) (Million US$)
Table 104. Boehringer Ingelheim Recent Development
Table 105. Johnson & Johnson Company Details
Table 106. Johnson & Johnson Business Overview
Table 107. Johnson & Johnson Product
Table 108. Johnson & Johnson Revenue in Ankylosing Spondylitis Treatment Business (2015-2020) (Million US$)
Table 109. Johnson & Johnson Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ankylosing Spondylitis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Disease-Modifying Anitrheumatic Drugs (DMARDs) Features
Figure 3. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Features
Figure 4. Biologics Features
Figure 5. Global Ankylosing Spondylitis Treatment Market Share by Application: 2020 VS 2026
Figure 6. Juveniles Case Studies
Figure 7. Adults Case Studies
Figure 8. Ankylosing Spondylitis Treatment Report Years Considered
Figure 9. Global Ankylosing Spondylitis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Ankylosing Spondylitis Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Ankylosing Spondylitis Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Ankylosing Spondylitis Treatment Market Share by Players in 2019
Figure 14. Global Top Ankylosing Spondylitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ankylosing Spondylitis Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Ankylosing Spondylitis Treatment Revenue in 2019
Figure 16. North America Ankylosing Spondylitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Ankylosing Spondylitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Ankylosing Spondylitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Ankylosing Spondylitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Ankylosing Spondylitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Ankylosing Spondylitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Ankylosing Spondylitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
強直性脊椎炎治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ankylosing Spondylitis Drug Market The global Ankylosing Spondylitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ankylosing Spondylitis Drug Scope and Market Size Ankylosin…- 非ステロイド性抗炎症薬（NSAID）の世界市場（～2026年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 自己免疫治療薬の世界市場（～2026年） Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by c…
- 炎症性腸疾患（IBD）治療の世界市場（～2026年） Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes t…
- エンセソパシー治療の世界市場（～2026年） Enthesopathy is derived from a combination of entheso means a specific structure within the musculoskeletal system and pathy means presence of pathology. The demand for enthesopathy treatment is expected to upsurge owing to the increasing number of sports injury, rising number of population going fo…